LinkedIn Logo

Returning February 2019


Presentation Title To Be Confirmed

by adamc | January 16, 2018 | posted in | No Comments

Stream 2

by Ridhi | November 29, 2017 | posted in | No Comments

Drinks Reception & Scientific Poster Session: Hosted by Transpharmation

After the formal presentations have finished, the learning and networking carries on. The poster session is an informal part of the conference agenda, allowing you to connect with your peers in a relaxed atmosphere and to continue to forge new and existing relationships. During this session, scientific posters will be presented on novel models, biomarkers and… Read more

by adamc | November 24, 2017 | posted in | No Comments

Targeting the Spread of Pathology Through Alternative Aetiologies

by adamc | | posted in | No Comments

Multi-Center Biomarker Development for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis

US, UK, Asian Cohorts for ALS diagnosis using whole blood samples UK cohort for ALS prognosis Relevance for other neurodegenerative and motor neuron diseases, like Alzheimer’s Disease, Parkinson’s, Dementia, Multiple Sclerosis, Depression and Schizophrenia

by adamc | | posted in | No Comments

Presentation to Be Confirmed

by adamc | | posted in | No Comments

Precision Medicine in a Data-rich Era – Challenges and Successful Bioinformatics Approaches

Highlighting the promise biomedical data holds as a powerful tool for enabling precision medicine Making effective use of big data in R&D processes to establish reliable hypotheses that can be tested with relatively small patient numbers in clinical trials given an incomplete biological understanding of the underlying disease Demonstrating real-world biomarker cases from non-oncology projects and presenting… Read more

by adamc | | posted in | No Comments

The Gut-Brain Axis: The Microbiome as a Versatile Target for Neurodegenerative Disease

Emerging data suggests that there is a link between changes in the gut microbiome and neurological diseases and disorders. This exciting bi-directional communication via the proposed gut-brain axis or GBA, has catapulted microbiota into the scientific spotlight for CNS disorders. However, with the size and complexity of the Gut-Brain Axis, there still remains a number… Read more

by Ridhi | October 27, 2017 | posted in | No Comments

The Promise & Challenge of Neuroimmune Therapeutics: Targets, Models, and the Science Behind the Innate Immune System’s Role in Neurodegenerative Disease

Whilst microglia have long been implicated in the pathology of neurodegenerative disease, recent accumulating evidence has pointed to these cell types as a driving factor in neuronal damage and disease progression for AD, PD and others. Although different models have been established to study these diseases and cell type strategies, their effectiveness has been limited…. Read more

by Ridhi | | posted in | No Comments

Exploring the Application of Gene Editing in the Treatment of CNS Disorders

Gene editing holds the potential for a transformative approach to the therapy of CNS disorders. The emergence of novel gene-editing tools such as CRISPR, TALEN, Zinc Finger Nucleases and Homologous Recombination opens new possibilities in the development of disease relevant animal models and, more importantly, in highly specific therapeutic interventions. In order for these technologies… Read more

by Ridhi | | posted in | No Comments